1,2,4-Triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione, 6,7,10,11-tetrahydro-3-(trifluoromethyl)-10-[(2,4,5-trifluorophenyl)methyl]-
|
|
1,2,4-Triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione, 6,7,10,11-tetrahydro-3-(trifluoromethyl)-10-[(2,4,5-trifluorophenyl)methyl]- 속성
- 밀도
- 1.67±0.1 g/cm3(Predicted)
- 용해도
- DMSO(약간 용해됨), 메탄올(약간 용해됨, 가열)
- 산도 계수 (pKa)
- 12.02±0.40(Predicted)
- 물리적 상태
- 고체
- 물리적 상태
- 단단한 모양
- 색상
- 흰색에서 황백색까지
안전
1,2,4-Triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione, 6,7,10,11-tetrahydro-3-(trifluoromethyl)-10-[(2,4,5-trifluorophenyl)methyl]- C화학적 특성, 용도, 생산
1,2,4-Triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione, 6,7,10,11-tetrahydro-3-(trifluoromethyl)-10-[(2,4,5-trifluorophenyl)methyl]- 준비 용품 및 원자재
원자재
준비 용품
1,2,4-Triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione, 6,7,10,11-tetrahydro-3-(trifluoromethyl)-10-[(2,4,5-trifluorophenyl)methyl]- 공급 업체
글로벌( 7)공급 업체
공급자 | 전화 | 이메일 | 국가 | 제품 수 | 이점 |
---|---|---|---|---|---|
hubei PharmaStandard Co., Ltd. | 027-19050701 13545374703 |
cbbspring@163.com | China | 324 | 58 |
Hubei Yangxin Medical Technology Co., Ltd. | 15374522761 |
3003392093@qq.com | China | 7933 | 55 |
QUALITY CONTROL SOLUTIONS LTD. | 13670046396 |
ORDERS@QCSRM.COM | China | 18820 | 58 |
Cato Research Chemicals Inc. | 020-81960175-877 18933936954 |
tianwen.zhan@cato-chem.com | China | 7696 | 58 |
Nanjing Huanuo Biomedical Technology Co., Ltd | 18913906212 |
2885426135@qq.com | China | 6580 | 58 |
Hubei De'ao Chemical Research Pharmaceutical Technology Co., Ltd | 18502726233 |
3641133981@qq.com | China | 9294 | 58 |
Guangzhou Zhenlin Pharmaceutical Technology Co., Ltd | 18102736234 18102736234 |
2208093734@qq.com | China | 6348 | 58 |
1,2,4-Triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione, 6,7,10,11-tetrahydro-3-(trifluoromethyl)-10-[(2,4,5-trifluorophenyl)methyl]- 관련 검색:
Sitagliptin Impurity 1
(R)-3-AMino-4-(2,4,5-trifluoro-phenyl)-butyric acid hydrochloride
Acetic acid, 2-chloro-, 2-(2-chloroacetyl)hydrazide
Benzenebutanoic acid, β-[[(3R)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-1-oxo-4-(2,4,5-trifluorophenyl)butyl]amino]-2,4,5-trifluoro-, (βR)-
tert-Butyl ((R)-4-Oxo-4-(((R)-4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)amino)-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamate
BOC-(S)-3-AMINO-4-(2,4,5-TRIFLUORO-PHENYL)-BUTYRIC ACID
BLDAVCZELRQXFP-OWOJBTEDSA-N
Sitagliptin N-Boc IMpurity
Sitagliptin Defuoro IMpurity 3
(R)-3-Amino-4-(2,4,5-trifluorophenyl)butyric acid
(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one
Sitagliptin DeaMino IMpurity 1